What is Rhythm Pharmaceuticals Inc (RYTM)?
Rhythm Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing therapies for rare genetic disorders related to obesity. The company focuses on conditions caused by deficiencies in the melanocortin-4 receptor pathway, which regulates appetite and energy balance. Its research and development efforts aim to create treatments that address the underlying genetic causes of these disorders. The company engages in clinical trials and collaborates with medical experts to advance its therapeutic candidates. It operates within the biotechnology sector, emphasizing precision medicine approaches for rare diseases. The company’s work contributes to expanding options for patients with limited treatment alternatives. Its strategy includes regulatory engagement and commercialization planning to bring novel therapies to market.
Rhythm Pharmaceuticals Inc Stock Price Today: Live Overview
The price today is shaped by live session fluctuations, with Rhythm Pharmaceuticals Inc trading at $85.78. It has moved within a daily range of $84.01 to $85.65, with a change of -0.852%.
FAQ: Rhythm Pharmaceuticals Inc (RYTM)
What is the current price of RYTM stock?
Rhythm Pharmaceuticals Inc's current price is $85.78.
Does RYTM pay dividends?
Rhythm Pharmaceuticals Inc does not pay dividends.
Does RYTM have a formal corporate presence or regional headquarters in the UAE?
Rhythm Pharmaceuticals Inc operates in the UAE exclusively through partners and distributors without a local office or subsidiary.
What is RYTM best known for?
The company is most famous for developing therapies for rare genetic diseases related to obesity.
What assets are typically shown together with RYTM?
Commonly shown alongside RYTM: GeoVax Labs, Inc., Ultragenyx Pharmaceutical Inc, Innventure Inc
Latest shares articles



